Absorption of nickel sulphate is variable among individuals. For maximum absorption, tablets should be taken orally at the beginning of the day (or any convenient time after having taken nothing but water for at least 7 hours). Take nothing but water for one hour after taking medication to aid absorption. Kg lbs Starting dose Max Daily dose 5-11 11-25 ¼ ½ 12-22 26-50 ½ 1 23-45 51-100 1 2 46-68 101-150 2 4 69-90 15...
www.PlymouthPharmaceuticals.comFederal law prohibits dispensing without a prescription.
ECZEMOL ®is a biochemical homeopathic medication indicated for the treatment of eczema. 27,29The active ingredients in each ECZEMOL ®tablet consist of the following: Potassium Bromide (Kali Bromatum) 1X, Sulphur 1X, and Nickel Sulphate (Niccolum Sulphuricum) 1X. These drug ingredients are listed in the Homoeopathic Pharmacopoeia of the United States (HPUS). 1
Inactive ingredients: Lactose, Fumaric Acid, and Magnesium Stearate.
Pharmacological class:Homeopathic drug.
Dosage form:Oral 300 mg scored tablet. May be swallowed whole, chewed or dissolved in the mouth and swallowed.
The active ingredients in ECZEMOL ®are simple biochemical compounds. The exact mechanism of action is unknown; however, it is believed ECZEMOL ®addresses a primary genetic biochemical defect.
POTASSIUM BROMIDEdissolves and dissociates in the digestive tract into its ionic constituents. Each tablet contains approximately 15 mg of bromide (calculated). Ionic bromide is rapidly and completely absorbed from the intestine and distributed almost exclusively in the extracellular fluids. 7,8Bromide is eliminated by the kidneys and the elimination half-life is 11-12 days. "Once a day" dosing will lead to a steady state concentration in about seven weeks. 7
SULPHURis a naturally occurring mineral that is an essential part of the human body. It exhibits anti-bacterial, anti-parasitic, fungicidal, and keratolytic properties. 26Each tablet contains approximately 1.5 mg of sulphur (calculated). Sulphur is highly water soluble and as a result is easily excreted by the body via sweat and urine. 22Since the sulphur found in ECZEMOL ®is a naturally occurring mineral, it is radically different from sulfa drugs (sulfonamide antibiotics). Therefore, patients who are allergic to sulfa drugs CAN safely take ECZEMOL ® .
NICKEL SULPHATEdissolves and dissociates in the digestive tract into its ionic constituents. Each tablet contains approximately 0.5 mg of ionic nickel (calculated). According to studies, 15% to 50% of ionic nickel is absorbed on a fasted stomach. 2Food markedly decreases the rate and extent of nickel absorption. 3,4Clinical studies show that serum concentrations of nickel are variable among patients after administering the same dosage. 5Peak serum nickel concentration is reached about two hours after oral administration. "Once a day" dosing leads to steady state serum concentrations in approximately one week. Nickel is in its highly stable divalent cation state and is therefore not expected to be metabolized to any significant degree in the body. Absorbed nickel is primarily excreted in the urine and elimination half-life is about 21 hours. 3,5Renal clearance is rapid and efficient, and nickel does not accumulate in the body. 6
A variety of controlled clinical studies have been performed using various sources of both nickel and bromide in over 300 subjects. Clinical efficacy and safety have been documented in a significant number of subjects. Published and unpublished reports are available upon request. 9,20,21
ECZEMOL ®is indicated for the treatment of moderate to severe eczema and atopic dermatitis. It has been found to work well with a variety of combination therapies.
Although there are no known contraindications, patients who are allergic to any ECZEMOL ®ingredient should consult a physician prior to taking the medication. (Refer to Section on Hypersensitivity)
Do not use if imprinted seal under bottle cap is missing or broken. Do not use if pregnant or nursing. If allergic to nickel or metal objects such as jewelry or if there is a history of blistering hand eczema, see PRECAUTIONSfor hypersensitivity information. Lactose intolerant patients may have gastrointestinal difficulty. This has very rarely been reported at the doses used.
Carefully adjust dosage to weight when treating young children. Use cautiously in setting of kidney disease. (see Dosage and Administration) If skin rash appears or if nervous symptoms persist, recur frequently, or are unusual, discontinue use.
Caution should be used when administering to patients with a history of contact sensitivity to nickel (common metal exposure) or if there is a history of vesicular hand eczema (dyshidrosis, pomphylox). Nickel allergy may be confirmed by a positive nickel patch test. Most patients with hand eczema, positive nickel allergy history, or a positive nickel patch test do nothave any untoward reaction to administration of ECZEMOL ®. If there is a history of nickel sensitivity or dyshidrotic hand eczema, begin with a very low dose and slowly increase to a recommended starting dose over a period of 5 weeks as tolerated, thus allowing progressive GI absorption *.
| Week | Amount of Time to Take
Medication Prior to Breakfast |
|---|---|
| Week 1 | With Breakfast |
| Week 2 | 15 min Prior |
| Week 3 | 30 min Prior |
| Week 4 | 45 min Prior |
| Week 5 and thereon | 1 hour Prior |
If new pruritic rashes occur or persist, discontinue ECZEMOL ®and treat appropriately. Do not use if there is a history of extra-cutaneous hypersensitivity to nickel or any ingredient in ECZEMOL ®.
Patients using ECZEMOL ®should receive the following information and instructions:
There are no known drug interactions.
No studies have been done on the carcinogenesis, mutagenesis, or impairment of fertility of ECZEMOL ®. No carcinogenesis or mutagenesis has been reported in multiple animal studies for oral administration of soluble nickel and bromide salts (active ingredients) even at very high doses. 10-14
KBr is not listed as a carcinogen by the NTP, IARC, and OSHA. 16
Sulphur is not listed as a carcinogen by the ACGIH, IARC, NIOSH, NTP, or OSHA. 25
Studies on experimental animals have never indicated that nickel, at any dose, is a carcinogen when introduced to the body orally. Furthermore, Nickel sulphate and other highly water soluble nickel salts, have never been known to induce carcinogenesis via any route of introduction including: oral, inhalation, cutaneous, IM, or IP. 10-12,15No adverse effects were noted on fertility or reproduction in a 3-generational study of albino Wistar rats fed up to 1000 ppm Ni per day, which is equivalent to 50 mg/kg body weight per day Ni. 15
Animal reproduction studies have not been conducted with ECZEMOL ®. ECZEMOL ®should not be given to a pregnant woman.
It is not known whether this drug is excreted in human milk. However, since many drugs are excreted in human milk, caution should be exercised when ECZEMOL ®is administered to a nursing woman.
Carefully adjust dosage to weight when treating young children.
ECZEMOL ®contains low doses of active ingredients. Therefore there are minimal known side effects. (see PRECAUTIONSfor hypersensitivity information)
Indications of toxicity due to oral overdosage of bromide may include nausea, vomiting, apathy, disturbed coordination, loss of memory, drowsiness, loss of emotional control, agitation, hallucination, tremors, depressed reflexes, stupor, and coma. Acute toxic reactions in humans have been reported at doses as low as 1000 mg. 19This level is 67 times the dose received in one tablet of ECZEMOL ®.
The oral rat LD 50for sulphur is reported to be greater than 5,000 mg/kg . 23This is more than 37,000 times the maximum dose recommended for ECZEMOL ®. (see Dosage) Ingestion of toxic levels of sulphur can cause sore throat, nausea, headache, gastrointestinal irritation, and possibly unconsciousness in severe cases. 24,25Sulphur poses such a remote risk that it is placed in the lowest toxic category possible, EPA Toxicity Category IV. 23
The oral rat LD 50for nickel sulphate hexahydrate is 275 mg/kg. 17Symptoms of toxicity due to oral overdosage of nickel sulphate may include nausea, vomiting, abdominal discomfort, diarrhea, giddiness, lassitude, headaches, cough, and shortness of breath. 18The lowest observed transitory toxic effects from human ingestion of soluble nickel salts is approximately 8 mg nickel/kg body weight. 18This is 180 times the maximum dose recommended for ECZEMOL ®. (See below)
Absorption of nickel sulphate is variable among individuals. For maximum absorption, tablets should be taken orally at the beginning of the day(or any convenient time after having taken nothing but water for at least 7 hours). Take nothing but water for one hour after taking medication to aid absorption.
| Kg | lbs | Starting
dose | Max Daily dose |
|---|---|---|---|
| 5-11 | 11-25 | ¼ | ½ |
| 12-22 | 26-50 | ½ | 1 |
| 23-45 | 51-100 | 1 | 2 |
| 46-68 | 101-150 | 2 | 4 |
| 69-90 | 151-200 | 3 | 6 |
| 91+ | 201+ | 4 | 8 |
Dosage should be adjusted and serum nickel and bromide levels should be followed. Steady state trough level should be drawn prior to ingesting the day's dose after one week of dosing or at appropriate intervals. Target trough serum nickel level is 20-40 mcg/L. (Caution: post dose peak levels are unreliable.) Treatment duration depends on the individual. Increase dose as needed on a monthly basis. Try b.i.d. dosing (upon rising and at bedtime) if max dose (see above) is not effective; do not exceed max daily dose.
In order to maintain symptomatic relief, medication may be continued at the same or reduced initial phase dose level.
Scored tablets, off white in color with green speckles, with
RxSales@PlymouthPharmaceuticals.com
www.PlymouthPharmaceuticals.com
Plymouth Pharmaceuticals Inc. dba LOMA LUX Laboratories; P.O. BOX 702418; Tulsa, OK 74170-2418
Phone 800.316.9636, 918.664.9882, Fax 918.664.9884
Revised 2.7.06 mn
NDC 61480-127-05
Homeopathic Medication
ECZEMOL ®
Indicated for treatment of
ECZEMA
100 Tablets
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0361480127053 | GTIN-13: 0361480127053 EAN-13: 0361480127053 GTIN-12: 361480127053 UPC-A: 361480127053 GTIN storage (14 digits): 00361480127053 | eczemol-02.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61480-127-05 | Eczemol | 100 in 1 BOTTLE | TABLET | 100 | 10 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61480-127-05 | EA - Each | 61480-127 | 6a53584a-de55-4b00-aaa7-aa785a70cd36 | 1 | 2015-10-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Nickel Sulfate | ACTIVE INGREDIENT | 4FLT4T3WUN | 3 | |
| Potassium Bromide | ACTIVE INGREDIENT | OSD78555ZM | 3 | |
| Sulfur | ACTIVE INGREDIENT | 70FD1KFU70 | 3 | |
| BROMIDE ION | ACTIVE MOIETY | 952902IX06 | 3 | |
| NICKEL CATION | ACTIVE MOIETY | OIS2CXW7AM | 3 | |
| Sulfur | ACTIVE MOIETY | 70FD1KFU70 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61480-127 | 61480-127-05 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POTASSIUM BROMIDE | OSD78555ZM | ACTIB |
| NICKEL SULFATE | 4FLT4T3WUN | ACTIB |
| SULFUR | 70FD1KFU70 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eczemol | POTASSIUM BROMIDE, NICKEL SULFATE, AND SULFUR | PLYMOUTH HEALTHCARE PRODUCTS LLC | 981e9f3d-b608-4a5e-92f8-895b22da12f4 | 2025-11-20 | Warnings, Adverse reactions | 61480-127-05 61480-127 61480012705 440c8a06-8ffb-f7af-e063-6394a90a7ccf 981e9f3d-b608-4a5e-92f8-895b22da12f4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.